Document is current
Any future updates will be listed below
-
Authors
Blake, Pamela https://orcid.org/0000-0002-5031-0416
Burstein, Rami
- License Information
-
More Information
Article History
Received: 7 April 2019
Accepted: 10 June 2019
First Online: 2 July 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: PB reports no competing interests.RB received grant support for his studies on migraine pathophysiology from Teva, Allergan, Dr. Reddy, and Trigemina; he also serves as a consultant to Alder Biopharm, Allergan, Amgen, Autonomic Technologies Inc., Avanir, Biohaven, Depomed, Dr. Reddy, Electrocore, Johnson and Johnson, Neurolief, Percept, Pernix, Strategic Science and Technologies, Teva, Theranica, Trigemina. Beth Israel Deaconess Medical Center and Dr. Burstein hold a provisional patent on the use of narrow band green light for the treatment of photophobia in migraine.
